A biotin-guided fluorescent-peptide drug delivery system for cancer treatment

Chemical Communications

Volumn 50, Issue 57, 2014, Pages 7690-7693

  Kim, Taeyoung ^a   Jeon, Hyun Mi ^b   Le, Hoa Thi ^b   Kim, Tae Woo ^b   Kang, Chulhun ^b   Kim, Jong Seung ^a  

^a Korea University   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOTIN; FLUORESCENT DYE; PEPTIDE; BIOTIN NAPHTHALIMIDE HJ INHIBITOR PEPTIDE; DISULFIDE; DRUG CARRIER; GLUTATHIONE; PRODRUG; UNCLASSIFIED DRUG;

CELL SURVIVAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; HEPG2 CELL LINE; HUMAN; PHYSIOLOGY; PROCEDURES; ARTICLE; CANCER THERAPY; CELL VIABILITY; CONFOCAL MICROSCOPY; CYCLIZATION; DISULFIDE BOND; ENDOPLASMIC RETICULUM; FLUORESCENCE;

ANTINEOPLASTIC AGENTS; BIOTIN; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; FLUORESCENT DYES; HEP G2 CELLS; HUMANS; PEPTIDES;

EID: 84903134707     PISSN: 13597345     EISSN: 1364548X     Source Type: Journal    
DOI: 10.1039/c4cc02878c     Document Type: Article

References (29)

1. C. M. Edwards, M. A. Cohen, S. R. Bloom, Q. J. Med. 1999, 92, 1
2. L. Sun, Mod. Chem. Appl. 2013, 1, 1
3. E. Koren, V. P. Torchilin, Trends Mol. Med. 2012, 18, 7
4. K. Jagadish, J. A. Camarero, J. Pept. Sci. 2010, 94, 611
5. K. C. L. Mulder, L. A. Lima, V. J. Miranda, S. C. Dias, O. L. Franco, Front. Microbiol. 2014, 4, 321
6. D. J. Craik, D. P. Fairlie, S. Liras, Chem. Biol. Drug Des. 2013, 81, 136
7. F. Madani, S. Lindberg, U. Langel, S. Futaki, J. Graslund, J. Biophys. 2011, 2011, 414729
8. P. Jarver, U. Langel, Biochim. Biophys. Acta 2006, 1758, 260
9. M. C. Garnett, Adv. Drug Delivery Rev. 2001, 53, 171
10. S. Jaracz, J. Chen, L. V. Kuznetsova, I. Ojima, Bioorg. Med. Chem. 2005, 13, 5043
11. H. Takeuchi, H. Yamamoto, Y. Kawashima, Adv. Drug Delivery Rev. 2001, 47, 39
12. E. Ruoslahti, S. N. Bhatia, M. J. Sailor, J. Cell Biol. 2010, 188, 759
13. S. Maiti, N. Park, J. H. Han, H. M. Jeon, J. H. Lee, S. Bhuniya, C. Kang, J. S. Kim, J. Am. Chem. Soc. 2013, 135, 4567
14. M. H. Lee, J. Y. Kim, J. H. Han, S. Bhuniya, J. L. Sessler, C. Kang, J. S. Kim, J. Am. Chem. Soc. 2012, 134, 12668
15. H. P. Lesph, M. U. Kaikkonen, J. T. Pikkarainen, S. Ylä-Herttuala, Expert Opin. Drug Delivery 2010, 7, 551
16. V. Dixit, J. Van den Bossche, D. M. Sherman, D. H. Thompson, R. P. Andres, Bioconjugate Chem. 2006, 17, 603
17. S. H. Lee, J. Y. Kim, J. Ko, J. Y. Lee, J. S. Kim, J. Org. Chem. 2004, 69, 2902
18. N. J. Curtin, Nat. Rev. Cancer 2012, 12, 801
19. J. L. Boldt, C. Pinilla, A. Segall, J. Biol. Chem. 2004, 279, 3472
20. C. W. Gunderson, A. Segall, Mol. Microbiol. 2006, 59, 1129
21. R. Holliday, Genet. Res. 1964, 5, 282
22. H. P. Lesph, M. U. Kaikkonen, J. T. Pikkarainen, S. Ylä-Herttuala, Expert Opin. Drug Delivery 2010, 7, 551
23. M. Toussaint, M.-A. Debreu-Fontaine, T. Maurice, P. Melnyk, Med. Chem. 2010, 6, 355
24. M. Lapeyre, J. Leprince, M. Massonneau, H. Oulyadi, P. Renard, A. Romieu, G. Turcatti, H. Vaudry, Chem. – Eur. J. 2006, 12, 3655
25. L. G. F. Patrick, A. Whiting, Dyes Pigm. 2002, 55, 123
26. D. Yuan, R. G. Brown, J. D. Hepworth, M. S. Alexiou, J. H. P. Tyman, J. Heterocycl. Chem. 2008, 45, 397
27. T. P. Akerboom, M. Bilzer, H. Sies, J. Biol. Chem. 1982, 257, 4248
28. D. M. Townsend, K. D. Tew, H. Tapiero, Biomed. Pharmacother. 2003, 57, 145
29. K. V. Kepple, N. Patel, P. Salamon, A. M. Segall, Nucleic Acids Res. 2008, 36, 5319